Alexander, G. E., M. R. DeLong, and P. L. Strick. 1986. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 9:357-381.
Alvarez, L. M., J. F. Cortés Sotres, S. Ortiz León, J. Estrella, and J. J. Sánchez Sosa. 2008. Computer program in the treatment for major depression and cognitive impairment in university students. Computers in Human Behavior 24(3):816-826.
American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders, 5th ed. Washington, DC: American Psychiatric Association.
Barker, A. D., C. C. Sigman, G. J. Kelloff, N. M. Hylton, D. A. Berry, and L. J. Esserman. 2009. I-SPY 2: An adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clinical Pharmacology & Therapeutics 86(1):97-100.
Bastos, A. G., L. S. Guimaraes, and C. M. Trentini. 2013. Neurocognitive changes in depressed patients in psychodynamic psychotherapy, therapy with fluoxetine and combination therapy. Journal of Affective Disorders 151(3):1066-1075.
Bora, E., B. J. Harrison, M. Yucel, and C. Pantelis. 2013. Cognitive impairment in euthymic major depressive disorder: A meta-analysis. Psychological Medicine 43(10):2017-2026.
Bortolato, B., A. F. Carvalho, and R. S. McIntyre. 2014. Cognitive dysfunction in major depressive disorder: A state-of-the-art clinical review. CNS & Neurological Disorders Drug Targets 13(10):1804-1818.
Bowie, C. R., M. Gupta, K. Holshausen, R. Jokic, M. Best, and R. Milev. 2013. Cognitive remediation for treatment-resistant depression: Effects on cognition and functioning and the role of online homework. Journal of Nervous and Mental Disease 201(8):680-685.
Buchanan, R. W., M. Davis, D. Goff, M. F. Green, R. S. Keefe, A. C. Leon, K. H. Nuechterlein, T. Laughren, R. Levin, E. Stover, W. Fenton, and S. R. Marder. 2005. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophrenia Bulletin 31(1):5-19.
Clark, L., S. R. Chamberlain, and B. J. Sahakian. 2009. Neurocognitive mechanisms in depression: Implications for treatment. Annual Review of Neuroscience 32:57-74.
Demirtas-Tatlidede, A., A. M. Vahabzadeh-Hagh, and A. Pascual-Leone. 2013. Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? Neuropharmacology 64:566-578.
Duman, R. S., and G. K. Aghajanian. 2012. Synaptic dysfunction in depression: Potential therapeutic targets. Science 338(6103):68-72.
Elgamal, S., M. C. McKinnon, K. Ramakrishnan, R. T. Joffe, and G. MacQueen. 2007. Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: A proof of principle study. Psychological Medicine 37(9):1229-1238.
Elliott, R., B. J. Sahakian, J. J. Herrod, T. W. Robbins, and E. S. Paykel. 1997. Abnormal response to negative feedback in unipolar depression: Evidence for a diagnosis specific impairment. Journal of Neurology, Neurosurgery & Psychiatry 63(1):74-82.
Etkin, A., B. Patenaude, Y. J. Song, T. Usherwood, W. Rekshan, A. F. Schatzberg, A. J. Rush, and L. M. Williams. 2014. A cognitive-emotional biomarker for predicting remission with antidepressant medications: A report from the iSPOT-D trial. Neuropsychopharmacology 40(6):1332-1342.
Fava, M., L. M. Graves, F. Benazzi, M. J. Scalia, D. V. Iosifescu, J. E. Alpert, and G. I. Papakostas. 2006. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. Journal of Clinical Psychiatry 67(11):1754-1759.
Fava, M., D. V. Iosifescu, P. Pedrelli, and L. Baer. 2009. Reliability and validity of the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire. Psychotherapy and Psychosomatics 78(2):91-97.
Fineberg, N. A., P. M. Haddad, L. Carpenter, B. Gannon, R. Sharpe, A. H. Young, E. Joyce, J. Rowe, D. Wellsted, D. J. Nutt, and B. J. Sahakian. 2013. The size, burden and cost of disorders of the brain in the U.K. Journal of Psychopharmacology 27(9):761-770.
Fitzgerald, P. B., A. Srithiran, J. Benitez, Z. Z. Daskalakis, T. J. Oxley, J. Kulkarni, and G. F. Egan. 2008. An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder. Human Brain Mapping 29(4):490-501.
Ghio, L., S. Gotelli, M. Marcenaro, M. Amore, and W. Natta. 2014. Duration of untreated illness and outcomes in unipolar depression: A systematic review and meta-analysis. Journal of Affective Disorders 152-154:45-51.
Goss, A. J., M. Kaser, S. G. Costafreda, B. J. Sahakian, and C. H. Fu. 2013. Modafinil augmentation therapy in unipolar and bipolar depression: A systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry 74(11):1101-1107.
Gould, F., L. S. McGuire, D. Durand, S. Sabbag, C. Larrauri, T. L. Patterson, E. W. Twamley, and P. D. Harvey. 2015. Self-assessment in schizophrenia: Accuracy of evaluation of cognition and everyday functioning. Neuropsychology. Advanced online publication, http://dx.doi.org/10.1037/neu0000175 (accessed May 15, 2015).
Green, M. F. 1996. What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry 153(3):321-330.
Green, M. F., K. H. Nuechterlein, J. M. Gold, D. M. Barch, J. Cohen, S. Essock, W. S. Fenton, F. Frese, E. Goldberg, R. K. Heaton, R. S. E. Keefe, R. S. Kern, H. Kraemer, E. Stover, D. R. Weinberger, S. Zalcman, and S. R. Marder. 2004. Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry 56:301-307.
Green, M. F., N. R. Schooler, R. S. Kern, F. J. Frese, W. Granberry, P. D. Harvey, C. N. Karson, N. Peters, M. Stewart, L. J. Seidman, J. Sonnenberg, W. S. Stone, D. Walling, E. Stover, and S. R. Marder. 2011. Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. American Journal of Psychiatry 168(4): 400-407.
Greenberg, P. E., A. A. Fournier, T. Sisitsky, C. T. Pike, and R. C. Kessler. 2015. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). Journal of Clinical Psychiatry 76(2):155-162.
Groves, S. J., R. J. Porter, J. Jordan, R. Knight, J. D. Carter, V. V. McIntosh, K. Fernando, C. M. Frampton, R. T. Mulder, C. Lacey, and P. R. Joyce. 2015. Changes in neuropsychological function after treatment with metacognitive therapy or cognitive behavior therapy for depression. Depression and Anxiety 32(6):437-444.
Harmer, C. J., G. M. Goodwin, and P. J. Cowen. 2009. Why do antidepressants take so long to work?: A cognitive neuropsychological model of antidepressant drug action. British Journal of Psychiatry 195(2):102-108.
Harvey, P. O., P. Fossati, J. B. Pochon, R. Levy, G. Lebastard, S. Lehericy, J. F. Allilaire, and B. Dubois. 2005. Cognitive control and brain resources in major depression: An fMRI study using the n-back task. NeuroImage 26(3):860-869.
Harvey, P. D., G. Paschall, and C. Depp. 2015. Factors influencing self-assessment of cognition and functioning in bipolar disorder: A preliminary study. Cognitive Neuropsychiatry 20(4):361-371.
Hay, M., D. W. Thomas, J. L. Craighead, C. Economides, and Rosenthal. 2014. Clinical development success rates for investigational drugs. Nature Biotechnology 32(1):40-51.
Heinrichs, R. W., and K. K. Zakzanis. 1998. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology 12(3):426-445.
Holmes, A. J., and D. A. Pizzagalli. 2008a. Response conflict and frontocingulate dysfunction in unmedicated participants with major depression. Neuropsychologia 46(12):2904-2913.
Holmes, A. J., and D. A. Pizzagalli. 2008b. Spatio-temporal dynamics of error processing dysfunctions in major depressive disorder. Archives of General Psychiatry 65(2):179-188.
Holmes, A. J., R. Bogdan, and D. A. Pizzagalli. 2010. Serotonin transporter genotype and action monitoring dysfunction: A possible substrate underlying increased vulnerability to depression. Neuropsychopharmacology 35(5):1186-1197.
Holtzheimer, P. E., and H. S. Mayberg. 2011. Stuck in a rut: Rethinking depression and its treatment. Trends in Neuroscience 34(1):1-9.
Insel, T., B. Cuthbert, M. Garvey, R. Heinssen, D. S. Pine, K. Quinn, C. Sanislow, and P. Wang. 2010. Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. American Journal of Psychiatry 167(7):748-751.
Insel, T. R., V. Voon, J. S. Nye, V. J. Brown, B. M. Altevogt, E. T. Bullmore, G. M. Goodwin, R. J. Howard, D. J. Kupfer, G. Malloch, H. M. Marston, D. J. Nutt, T. W. Robbins, S. M. Stahl, M. D. Tricklebank, J. H. Williams, and B. J. Sahakian. 2013. Innovative solutions to novel drug development in mental health. Neuroscience & Biobehavioral Reviews 37(10 Pt 1):2438-2444.
Jaeger, J., S. Berns, S. Uzelac, and S. Davis-Conway. 2006. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Research 145(1):39-48.
Katona, C., T. Hansen, and C. K. Olsen. 2012. A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. International Clinical Psychopharmacology 27(4):215-223.
Keefe, R. S., M. Poe, T. M. Walker, J. W. Kang, and P. D. Harvey. 2006. The Schizophrenia Cognition Rating Scale: An interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. American Journal of Psychiatry 163(3):426-432.
Keefe, R. S., S. M. McClintock, R. M. Roth, P. M. Doraiswamy, S. Tiger, and M. Madhoo. 2014. Cognitive effects of pharmacotherapy for major depressive disorder: A systematic review. Journal of Clinical Psychiatry 75(8):864-876.
Kola, I., and J. Landis. 2004. Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery 3(8):711-715.
Lawrence, A. D., B. J. Sahakian, and T. W. Robbins. 1998. Cognitive functions and corticostriatal circuits: Insights from Huntington’s disease. Trends in Cognitive Sciences 2(10):379-388.
Lee, R. S. C., D. F. Hermens, M. A. Porter, and M. A. Redoblado-Hodge. 2012. A meta-analysis of cognitive deficits in first-episode major depressive disorder. Journal of Affective Disorders 140(2):113-124.
Liston, C., A. C. Chen, B. D. Zebley, A. T. Drysdale, R. Gordon, B. Leuchter, H. U. Voss, B. J. Casey, A. Etkin, and M. J. Dubin. 2014. Default mode network mechanisms of transcranial magnetic stimulation in depression. Biological Psychiatry 76(7):517-526.
Madhoo, M., R. S. Keefe, R. M. Roth, A. Sambunaris, J. Wu, M. H. Trivedi, C. S. Anderson, and R. Lasser. 2014. Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder. Neuropsychopharmacology 39(6):1388-1398.
Mahableshwarkar, A. R., J. Zajecka, W. Jacobson, Y. Chen, and R. S. Keefe. 2015. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology 40:2025-2037.
Marquez-Ruiz, J., R. Leal-Campanario, R. Sanchez-Campusano, B. Molaee-Ardekani, F. Wendling, P. C. Miranda, G. Ruffini, A. Gruart, and J. M. Delgado-Garcia. 2012. Transcranial direct-current stimulation modulates synaptic mechanisms involved in associative learning in behaving rabbits. Proceedings of the National Academy of Sciences of the United States of America 109(17):6710-6715.
Matsuo, K., D. C. Glahn, M. A. Peluso, J. P. Hatch, E. S. Monkul, P. Najt, M. Sanches, F. Zamarripa, J. Li, J. L. Lancaster, P. T. Fox, J. H. Gao, and J. C. Soares. 2007. Prefrontal hyperactivation during working memory task in untreated individuals with major depressive disorder. Molecular Psychiatry 12(2):158-66.
Mausbach, B. T., P. D. Harvey, A. E. Pulver, C. A. Depp, P. S. Wolyniec, M. H. Thornquist, J. R. Luke, J. A. McGrath, C. R. Bowie, and T. L. Patterson. 2010. Relationship of the brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder. Bipolar Disorders 12(1):45-55.
McGurk, S. R., E. W. Twamley, D. I. Sitzer, G. J. McHugo, and K. T. Mueser. 2007. A meta-analysis of cognitive remediation in schizophrenia. American Journal of Psychiatry 164(12):1791-1802.
McIntyre, R. S., S. Lophaven, and C. K. Olsen. 2014. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. International Journal of Neuropsychopharmacology 17(10):1557-1567.
Meusel, L. A., G. B. Hall, P. Fougere, M. C. McKinnon, and G. M. MacQueen. 2013. Neural correlates of cognitive remediation in patients with mood disorders. Psychiatry Research 214(2):142-152.
Mondino, M., D. Bennabi, E. Poulet, F. Galvao, J. Brunelin, and E. Haffen. 2014. Can transcranial Direct Current Stimulation (tDCS) alleviate symptoms and improve cognition in psychiatric disorders? World Journal of Biological Psychiatry 15(4):261-275.
Morimoto, S. S., B. E. Wexler, J. Liu, W. Hu, J. Seirup, and G. S. Alexopoulos. 2014. Neuroplasticity-based computerized cognitive remediation for treatment-resistant geriatric depression. Nature Communications 5:4579.
Muller, U., J. B. Rowe, T. Rittman, C. Lewis, T. W. Robbins, and B. J. Sahakian. 2013. Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology 64:490-495.
Murrough, J. W., B. Iacoviello, A. Neumeister, D. S. Charney, and D. V. Iosifescu. 2011. Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies. Neurobiology of Learning and Memory 96(4):553-563.
Naismith, S. L., M. A. Redoblado-Hodge, S. J. Lewis, E. M. Scott, and I. B. Hickie. 2010. Cognitive training in affective disorders improves memory: A preliminary study using the NEAR approach. Journal of Affective Disorders 121(3):258-262.
Nitsche, M. A., K. Fricke, U. Henschke, A. Schlitterlau, D. Liebetanz, N. Lang, S. Henning, F. Tergau, and W. Paulus. 2003. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. Journal of Physiology 553(Pt 1):293-301.
Norbury, R., B. Godlewska, and P. J. Cowen. 2014. When less is more: A functional magnetic resonance imaging study of verbal working memory in remitted depressed patients. Psychological Medicine 44(6):1197-1203.
Olesen, J., A. Gustavsson, M. Svensson, H. U. Wittchen, B. Jonsson, CDBE Study Group, and Council European Brain. 2012. The economic cost of brain disorders in Europe. European Journal of Neurology 19(1):155-162.
Owens, M., I. M. Goodyer, P. Wilkinson, A. Bhardwaj, R. Abbott, T. Croudace, V. Dunn, P. B. Jones, N. D. Walsh, M. Ban, and B. J. Sahakian. 2012. 5-HTTLPR and early childhood adversities moderate cognitive and emotional processing in adolescence. PLoS ONE 7(11):e48482.
Owens, M., J. Herbert, P. B. Jones, B. J. Sahakian, P. O. Wilkinson, V. J. Dunn, T. J. Croudace, and I. M. Goodyer. 2014. Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proceedings of the National Academy of Sciences of the United States of America 111(9):3638-3643.
Pedrelli, P., L. Baer, D. V. Iosifescu, and M. Fava. 2010. Relationship between residual symptoms of depression and self-reported cognitive impairment. CNS Spectrums 15(1):46-51.
Pizzagalli, D. A. 2011. Frontocingulate dysfunction in depression: Toward biomarkers of treatment response. Neuropsychopharmacology 36(1):183-206.
Pizzagalli, D. A., L. A. Peccoralo, R. J. Davidson, and J. D. Cohen. 2006. Resting anterior cingulate activity and abnormal responses to errors in subjects with elevated depressive symptoms: A 128-channel EEG study. Human Brain Mapping 27(3):185-201.
Pratt, L. A. and D. J. Brody. 2014. Depression in the U.S. household population, 2009-2012. National Center for Health Statistics Data Brief 172:1-8. http://www.cdc.gov/nchs/data/databriefs/db172.pdf (accessed June 23, 2015).
Pringle, A., M. Browning, E. Parsons, P. J. Cowen, and C. J. Harmer. 2013. Early markers of cognitive enhancement: Developing an implicit measure of cognitive performance. Psychopharmacology (Berl) 230(4):631-638.
Raskin, J., C. G. Wiltse, A. Siegal, J. Sheikh, J. Xu, J. J. Dinkel, B. T. Rotz, and R. C. Mohs. 2007. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial. American Journal of Psychiatry 164(6):900-909.
Reichenberg, A., P. D. Harvey, C. R. Bowie, R. Mojtabai, J. Rabinowitz, R. K. Heaton, and E. Bromet. 2009. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophrenia Bulletin 35(5):1022-1029.
Roiser, J. P., and B. J. Sahakian. 2013. Hot and cold cognition in depression. CNS Spectrums 18(3):139-149.
Roiser, J. P., R. Elliott, and B. J. Sahakian. 2012. Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 37(1):117-136.
Rose, E. J., E. Simonotto, and K. P. Ebmeier. 2006. Limbic over-activity in depression during preserved performance on the n-back task. NeuroImage 29(1):203-215.
Rush, A. J., M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, J. W. Stewart, D. Warden, G. Niederehe, M. E. Thase, P. W. Lavori, B. D. Lebowitz, P. J. McGrath, J. F. Rosenbaum, H. A. Sackeim, D. J. Kupfer, J. Luther, and M. Fava. 2006. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry 163(11):1905-1917.
Sahakian, B. J., and A. M. Owen. 1992. Computerized assessment in neuropsychiatry using CANTAB: Discussion paper. Journal of the Royal Society of Medicine 85(7):399-402.
Sahakian, B. J., A. B. Bruhl, J. Cook, C. Killikelly, G. Savulich, T. Piercy, S. Hafizi, J. Perez, E. Fernandez-Egea, J. Suckling, and P. B. Jones. In Press. The impact of neuroscience on society: Cognitive enhancement in neuropsychiatric disorders and in healthy people. Philosophical Transactions of the Royal Society B.
Scoriels, L., J. H. Barnett, P. K. Soma, B. J. Sahakian, and P. B. Jones. 2012. Effects of modafinil on cognitive functions in first episode psychosis. Psychopharmacology (Berl) 220(2):249-258.
Shiroma, P. R., P. Thuras, B. Johns, and K. O. Lim. 2014. Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression. International Journal of Geriatric Psychiatry 29(11):1132-1139.
Simon, G. E. 2000. Long-term prognosis of depression in primary care. Bulletin of the World Health Organization 78(4):439-445.
Snyder, H. R. 2013. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review. Psychological Bulletin 139(1):81-132.
Stone, M., T. Laughren, M. L. Jones, M. Levenson, P. C. Holland, A. Hughes, T. A. Hammad, R. Temple, and G. Rochester. 2009. Risk of suicidality in clinical trials of antidepressants in adults: Analysis of proprietary data submitted to U.S. Food and Drug Administration. BMJ 339:b2880.
Tortella, G., P. M. Selingardi, M. L. Moreno, B. P. Veronezi, and A. R. Brunoni. 2014. Does non-invasive brain stimulation improve cognition in major depressive disorder? A systematic review. CNS & Neurological Disorders Drug Targets 13(10):1759-1769.
Trivedi, M. H., and T. L. Greer. 2014. Cognitive dysfunction in unipolar depression: Implications for treatment. Journal of Affective Disorders 152-154:19-27.
Turner, D. C., T. W. Robbins, L. Clark, A. Aron, J. Dowson, and B. J. Sahakian. 2003. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 165(3):260-269.
Turner, D. C., L. Clark, E. Pomarol-Clotet, P. McKenna, T. W. Robbins, and B. J. Sahakian. 2004a. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29(7):1363-1373.
Turner, D. C., L. Clark, J. Dowson, T. W. Robbins, and B. J. Sahakian. 2004b. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biological Psychiatry 55(10):1031-1040.
Undurraga, J., and R. J. Baldessarini. 2012. Randomized, placebo-controlled trials of antidepressants for acute major depression: Thirty-year meta-analytic review. Neuropsychopharmacology 37(4):851-864.
Walsh, N. D., S. C. Williams, M. J. Brammer, E. T. Bullmore, J. Kim, J. Suckling, M. T. Mitterschiffthaler, A. J. Cleare, E. M. Pich, M. A. Mehta, and C. H. Fu. 2007. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biological Psychiatry 62(11):1236-1243.
Walter, H., R. C. Wolf, M. Spitzer, and N. Vasic. 2007. Increased left prefrontal activation in patients with unipolar depression: An event-related, parametric, performance-controlled fMRI study. Journal of Affective Disorders 101(1-3):175-185.
Wang, P. S., M. Angermeyer, G. Borges, R. Bruffaerts, W. T. Chiu, D. E. Girolamo, G. J. Fayyad, O. Gureje, J. M. Haro, Y. Huang, R. C. Kessler, V. Kovess, D. Levinson, Y. Nakane, M. A. Oakley Brown, J. H. Ormel, J. Posada-Villa, S. Aguilar-Gaxiola, J. Alonso, S. Lee, S. Heeringa, B. E. Pennell, S. Chatterji, and T. B. Ustun. 2007. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry 6(3):177-185.
WHO (World Health Organization). 2008. The global burden of disease: 2004 update. Geneva, Switzerland: WHO.
Zarate, C. A., Jr., J. B. Singh, P. J. Carlson, N. E. Brutsche, R. Ameli, D. A. Luckenbaugh, D. S. Charney, and H. K. Manji. 2006. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 63(8):856-864.
This page intentionally left blank.